Thomas Silfverberg
PhD student at Center for Clinical Research Dalarna
- E-mail:
- thomas.silfverberg@uu.se
- Visiting address:
- Centrum för Klinisk Forskning Dalarna
- Postal address:
- Nissers väg 3
791 82 FALUN
Download contact information for Thomas Silfverberg at Center for Clinical Research Dalarna
PhD student at Department of Medical Sciences; Haematology
- E-mail:
- thomas.silfverberg@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, ing 101, plan 4
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, ing 100, plan 2
751 85 Uppsala
Download contact information for Thomas Silfverberg at Department of Medical Sciences; Haematology
Publications
Recent publications
-
Part of eJHaem, 2026
- DOI for Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study
- Download full text (pdf) of Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study
-
2025
-
Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 966-974, 2025
- DOI for Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis
- Download full text (pdf) of Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis
-
Part of Multiple Sclerosis Journal, p. 455-463, 2025
- DOI for Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis
- Download full text (pdf) of Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis
-
Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 125-133, 2024
- DOI for Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
- Download full text (pdf) of Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
All publications
Articles in journal
-
Part of eJHaem, 2026
- DOI for Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study
- Download full text (pdf) of Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study
-
Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 966-974, 2025
- DOI for Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis
- Download full text (pdf) of Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis
-
Part of Multiple Sclerosis Journal, p. 455-463, 2025
- DOI for Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis
- Download full text (pdf) of Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis
-
Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 125-133, 2024
- DOI for Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
- Download full text (pdf) of Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
-
Part of Bone Marrow Transplantation, p. 1601-1610, 2024
- DOI for BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis
- Download full text (pdf) of BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis
-
Part of Upsala Journal of Medical Sciences, 2022
- DOI for Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study
- Download full text (pdf) of Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study
-
Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 189-194, 2021
- DOI for Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study
- Download full text (pdf) of Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study
Comprehensive doctoral thesis
-
2025